01 1Zithromax
02 9Zithromax/Zmax
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2019 Revenue in Millions : 336
2018 Revenue in Millions : 326
Growth (%) : 3
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2020 Revenue in Millions : 276
2019 Revenue in Millions : 336
Growth (%) : -18
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2021 Revenue in Millions : 278
2020 Revenue in Millions : 276
Growth (%) : 1
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2022 Revenue in Millions : 331
2021 Revenue in Millions : 278
Growth (%) : 19
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2023 Revenue in Millions : 406
2022 Revenue in Millions : 331
Growth (%) : 23
Main Therapeutic Indication : Anti-bacterial
Currency : USD
2014 Revenue in Millions : -19.10%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Anti-bacterial
Currency : USD
2015 Revenue in Millions : 311
2014 Revenue in Millions : 275
Growth (%) : -12%
Main Therapeutic Indication : Anti-Bacterial
Currency : USD
2016 Revenue in Millions : 272
2015 Revenue in Millions : 275
Growth (%) : -1
Main Therapeutic Indication : Anti-bacterial
Currency : USD
2017 Revenue in Millions : 270
2016 Revenue in Millions : 272
Growth (%) : -1
Main Therapeutic Indication : Anti-Bacterial
Currency : USD
2018 Revenue in Millions : 0
2017 Revenue in Millions : 270
Growth (%) : -100%
LOOKING FOR A SUPPLIER?